# FDA Inspection 865425 - Biomat USA, Inc. - February 05, 2014

Source: https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/10b95b7f-8631-49fc-9e4b-42829753a157
Source feed: FDA_Inspections

> FDA Inspection 865425 for Biomat USA, Inc. on February 05, 2014. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 865425
- Company Name: Biomat USA, Inc.
- Inspection Date: 2014-02-05
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1071044 - 2018-10-18](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/50f2f7ed-a3fb-498e-a0af-1f0360d52951)
- [FDA Inspection 988681 - 2016-10-06](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/c3184c29-c0de-470f-b0dc-74cae47b590e)
- [FDA Inspection 785185 - 2012-04-24](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/7ed59914-3936-4e1e-8527-8102e82d79a6)
- [FDA Inspection 669894 - 2010-06-23](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/f1291b36-28f6-4286-ae6b-e4f7d2fa203e)

Company: https://www.globalkeysolutions.net/companies/biomat-usa-inc/3d78beed-9bd4-4c2a-8a22-7ace9fbd1a46

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d